Activation of descending pain-facilitatory pathways from the rostral ventromedial medulla by cholecystokinin elicits release of prostaglandin-E2 in the spinal cord
Authors:
- David S. HermanDHDavid S. Herman
- Tally M. Largent-MilnesTLTally M. Largent-Milnes
- Hamid BadghisiHBHamid Badghisi
- Konstantina ZuberKZKonstantina Zuber
- Shannon C. HoltSHShannon C. Holt
- Josephine LaiJLJosephine Lai
- Frank PorrecaFPFrank Porreca
- Todd W. VanderahTVTodd W. Vanderah
- 1 January 2012
- journal article
- Published by Wolters Kluwer Health in Pain
- Vol. 153 (1) , 86-94
Abstract
Cholecystokinin (CCK) has been suggested to be both pro-nociceptive and "anti-opioid" by actions on pain-modulatory cells within the rostral ventromedial medulla (RVM). One consequence of activation of RVM CCK₂ receptors may be enhanced spinal nociceptive transmission; but how this might occur, especially in states of pathological pain, is unknown. Here, in vivo microdialysis was used to demonstrate that levels of RVM CCK increased by approximately 2-fold after ligation of L₅/L₆ spinal nerves (SNL). Microinjection of CCK into the RVM of naïve rats elicited hypersensitivity to tactile stimulation of the hindpaw. In addition, RVM CCK elicited a time-related increase in (prostaglandin-E₂) PGE₂ measured in cerebrospinal fluid from the lumbar spinal cord. The peak increase in spinal PGE₂ was approximately 5-fold and was observed at approximately 80 minutes post-RVM CCK, a time coincident with maximal RVM CCK-induced mechanical hypersensitivity. Spinal administration of naproxen, a nonselective COX-inhibitor, significantly attenuated RVM CCK-induced hindpaw tactile hypersensitivity. RVM-CCK also resulted in a 2-fold increase in spinal 5-hydroxyindoleacetic acid (5-HIAA), a 5-hydoxytryptophan (5-HT) metabolite, as compared with controls, and mechanical hypersensitivity that was attenuated by spinal application of ondansetron, a 5-HT₃ antagonist. The present studies suggest that chronic nerve injury can result in activation of descending facilitatory mechanisms that may promote hyperalgesia via ultimate release of PGE₂ and 5-HT in the spinal cord.Keywords
This publication has 64 references indexed in Scilit:
- Central modulation of painJournal of Clinical Investigation, 2010
- Lack of analgesic efficacy of spinal ondansetron on thermal and mechanical hypersensitivity following spinal nerve ligation in the ratBrain Research, 2010
- Role of Spinal Cyclooxygenase in Human Postoperative and Chronic PainAnesthesiology, 2010
- Effects of Intrathecal Ketorolac on Human Experimental PainAnesthesiology, 2010
- Neuropathic pain is maintained by brainstem neurons co-expressing opioid and cholecystokinin receptorsBrain, 2008
- Descending control of painProgress in Neurobiology, 2002
- An excitatory role for 5-HT in spinal inflammatory nociceptive transmission; state-dependent actions via dorsal horn 5-HT3 receptors in the anaesthetized ratPain, 2000
- Choosing the Right Nonsteroidal Anti-Inflammatory Drug for the Right PatientClinical Pharmacokinetics, 2000
- Lidocaine in the rostroventromedial medulla and the periaqueductal gray attenuates allodynia in neuropathic ratsNeuroscience Letters, 1996
- Up‐regulation of cyclooxygenase‐2 mRNA in the rat spinal cord following peripheral inflammationFEBS Letters, 1996